Abstract
Treatment of newborn rats with 10 μg/g of nerve growth factor for 10 days enhanced not only the growth but also the differentiation of neuroblasts in superior cervical ganglia. These morphological changes were accompanied by selective induction of tyrosine hydroxylase and dopamine β-hydroxylase (EC 1.14.2.1), whereas the total and specific activities of other enzymes involved in biosynthesis or metabolic degradation of norepinephrine rose only in proportion to the increase in volume of the sympathetic ganglia. There are remarkable similarities between this effect of nerve growth factor and the induction of trans-synaptic enzymes by increased activity of the sympathetic nervous system.
Keywords: dopa decarboxylase, monoamine oxidase
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bocchini V., Angeletti P. U. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc Natl Acad Sci U S A. 1969 Oct;64(2):787–794. doi: 10.1073/pnas.64.2.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CLELAND W. W. Computer programmes for processing enzyme kinetic data. Nature. 1963 May 4;198:463–465. doi: 10.1038/198463a0. [DOI] [PubMed] [Google Scholar]
- Håkanson R., Owman C. Pineal dopa decarboxylase and monoamine oxidase activities as related to the monoamine stores. J Neurochem. 1966 Jul;13(7):597–605. doi: 10.1111/j.1471-4159.1966.tb11956.x. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Levi-Montalcini R., Angeletti P. U. Nerve growth factor. Physiol Rev. 1968 Jul;48(3):534–569. doi: 10.1152/physrev.1968.48.3.534. [DOI] [PubMed] [Google Scholar]
- Levi-Montalcini R., Caramia F., Luse S. A., Angeletti P. U. In vitro effects of the nerve growth factor on the fine structure of the sensory nerve cells. Brain Res. 1968 May;8(2):347–362. doi: 10.1016/0006-8993(68)90054-1. [DOI] [PubMed] [Google Scholar]
- Levi-Montalcini R. The nerve growth factor: its mode of action on sensory and sympathetic nerve cells. Harvey Lect. 1966;60:217–259. [PubMed] [Google Scholar]
- Levitt M., Gibb J. W., Daly J. W., Lipton M., Udenfriend S. A new class of tyrosine hydroxylase inhibitors and a simple assay of inhibition in vivo. Biochem Pharmacol. 1967 Jul 7;16(7):1313–1321. doi: 10.1016/0006-2952(67)90162-1. [DOI] [PubMed] [Google Scholar]
- Molinoff P. B., Brimijoin S., Weinshilboum R., Axelrod J. Neurally mediated increase in dopamine-beta-hydroxylase activity. Proc Natl Acad Sci U S A. 1970 Jun;66(2):453–458. doi: 10.1073/pnas.66.2.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mueller R. A., Thoenen H., Axelrod J. Inhibition of trans-synaptically increased tyrosine hydroxylase activity by cycloheximide and actinomycin D. Mol Pharmacol. 1969 Sep;5(5):463–469. [PubMed] [Google Scholar]
- WILKINSON G. N. Statistical estimations in enzyme kinetics. Biochem J. 1961 Aug;80:324–332. doi: 10.1042/bj0800324. [DOI] [PMC free article] [PubMed] [Google Scholar]